MedTrace Logo

TyG Index Levels in Klinefelter Syndrome

NCT05014997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-08-20

No results posted yet for this study

Summary

It is well known that the frequency of cardiometabolic diseases are increased in patients with Klinefelter Syndrome. The triglyceride-glucose index (TyG index) is a simple surrogate marker of insulin resistance and is also associated with various cardiometabolic diseases. The aim of this study to investigate the TyG index levels and its relationship with insulin resistance and endothelial dysfunction in patients with KS.

Conditions

  • Cardiac Event
  • Klinefelter Syndrome
  • Endothelial Dysfunction

Interventions

OTHER

no intervention

this study was designed as retrospective observational study

Sponsors & Collaborators

  • Gulhane School of Medicine

    lead OTHER

Principal Investigators

  • Alper Sonmez, Prof. · Health Sciences University, Gulhane School of Medicine, dep. of Endocrinology and Metabolism, Turkey

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-10
Primary Completion
2014-10-01
Completion
2017-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05014997 on ClinicalTrials.gov